CKGSB Knowledge

China-focused leadership and business analysis

  • Know China
    • Chinese Economy
      • Airline Industry
      • Agriculture
      • Automobile Industry
      • Business Conditions Index
      • Logistics
      • Manufacturing
      • Movie Industry
      • Real Estate
      • Retail
      • Tourism
    • Society
      • Consumers
      • Culture
      • Demographics
      • Sports
    • Economics
    • Employment
    • Environment
    • Policy and Law
    • Resources
  • Finance
    • Internet Finance
    • Banking
    • Stock Markets
    • Private Equity
  • Digital Economy
    • eCommerce
    • Technology
    • Digital Marketing
    • O2O
  • Connections
    • Economy
    • Emerging Economies
    • International Trade
    • Globalization
  • Winning in China
    • Multinationals in China
    • Joint Ventures
    • Mergers and Acquisitions
  • Best Practice
    • Marketing
    • Management
    • Creativity
    • Branding
    • Social Good
      • CSR
      • Social Entrepreneurship
      • Sustainability
    • Entrepreneurship
    • Innovation
    • Strategy
    • Intellectual Property
    • Supply Chain
    • Talent
  • ExpertSpeak
    • Conversations
    • C-Suite
    • The Thinker Interview
    • The Chinapreneurs
    • Invisible Hand Revealed
    • Opinion

Climate of Mistrust: China’s Vaccine Dilemma

August 29, 2019 By Timothy Ang

After a stream of scandals and medical incidents, the Chinese public appears to be losing faith in drugs made in China. What are the implications for domestic and international pharmaceutical companies?

Filed Under: All Articles, China, Chinese Economy, Economy, Know China, Policy and Law, Society Tagged With: Healthcare, Pharmaceuticals

China Roundup: Rules on Foreign Investment in China’s Healthcare Sector Eased and Alibaba’s SingPost stake

May 30, 2014 By Neelima Mahajan

  The week that was: Government eases regulation on foreign investment in China’s healthcare sector; Alibaba picks up a 10.35% stake in Singapore Post; and the government’s pricing and corruption crackdown squeezes profits of pharmaceutical companies in China. Mending China’s Healthcare System China’s healthcare system is in urgent need of an overhaul (for a detailed […]

Filed Under: All Articles, China Round-up, Digital Economy, eCommerce, Finance, Joint Ventures, Know China, Logistics, Policy and Law, Winning in China Tagged With: Alibaba, China's Healthcare System, Corruption, E-Commerce, Foreign Investment, Government Control, Logistics, Pharmaceuticals, Slider, Tmall

Stem Cell Research in China: Regenerative Economics

May 5, 2014 By Colin Shek

What is the state of stem cell research in China? Who is positioned to make the most money from stem cell therapy, and who or what will stand in their way? Hours after delivering her first baby, Oscar, in November 2011 at the International Peace Maternity and Child Health Hospital in Shanghai, Cecilia Huang readily […]

Filed Under: All Articles, Infographics, Know China, Society, Technology Tagged With: Healthcare, Medicine, Pharmaceuticals, Research, Science, Slider, Stem Cell

Traditional Chinese Medicine: Business Blockbuster or False Fad?

January 8, 2013 By David Friesen

Tong Ren Tang is a household name in China. The pharmacy specializing in traditional Chinese medicine (TCM) has been around since 1669. Legend has it that Tong Ren Tang was set up as the royal pharmacy for the palace of the Qing Dynasty. The dynasty came and went, but Tong Ren Tang withstood the test […]

Filed Under: All Articles, China, Culture, Know China Tagged With: Exports, Healthcare, Pharmaceuticals, Slider, Tong Ren Tang, Traditional Chinese Medicine

About

Information, analysis, and interviews about the Chinese economy and doing business in China, from the people who know it best. Presented by the Cheung Kong Graduate School of Business, China's leading business school.


The Knowledge Newsletter

Keep up with CKGSB Knowledge: Subscribe to our weekly newsletter.

Read the Knowledge Magazine

RSS CKGSB News & Events

  • CKGSB Economist Develops Dynamic Model for Reopening Strategies amid COVID-19
  • Cheung Kong Graduate School of Business and Johns Hopkins Carey Business School Launch Dual Degree Master’s Program
  • What 500 years of history tells us about the long-term economic impact of pandemics
  • CKGSB Convenes Global Opinion Leaders to Advance Gender Equality
  • CKGSB MBA Program Hosted Johns Hopkins Carey Business School Students in the 2021 New Semester

About Us

  • CKGSB Knowledge Reader Survey
  • Contact
  • Copyright Statement
  • Know What’s Next for Business in China and Beyond
  • Publications
  • The CKGSB Knowledge team

Follow us

RSSTwitterFacebookLinkedinYoutube

Search

Magazine

Newsletter

Keep up with CKGSB Knowledge: Subscribe to our weekly newsletter.

RSS CKGSB News & Events

  • CKGSB Economist Develops Dynamic Model for Reopening Strategies amid COVID-19
  • Cheung Kong Graduate School of Business and Johns Hopkins Carey Business School Launch Dual Degree Master’s Program
  • What 500 years of history tells us about the long-term economic impact of pandemics
  • CKGSB Convenes Global Opinion Leaders to Advance Gender Equality

Copyright © Cheung Kong Graduate School of Business. All Rights Reserved. ICP1057951